American Society of Clinical Oncology

SHERPA: White

People

  1. Morris
    Morris
  2. Fox
    Fox
  3. Scher
    Scher
  4. Dickson
    Dickson
  5. Gollub
    Gollub
  6. Saltz
    Saltz
  7. Carrasquillo
    Carrasquillo
  8. D'Angelo
    D'Angelo
  9. Do
    Do
  10. Ho
    Ho

Groups

  1. Radiology, Department of (27)
  2. Department of Medicine (22)
  3. Solid Tumor Oncology Division (22)
  4. Body Imaging Service (14)
  5. GSK Faculty (14)
  6. Molecular Imaging and Therapy Service (13)
  7. Center for Pancreatic Cancer Research (9)
  8. Molecular Pharmacology and Chemistry Program Faculty (9)
  9. Nursing (9)
  10. Sloan Kettering Institute Faculty (9)
Search Within
  1. "2012"
  2. "Radiology, Department of"
Formats
  1. Meeting Abstract (23)
  2. Journal Article (4)
Groups
  1. Radiology, Department of (27)
  2. Department of Medicine (22)
  3. Solid Tumor Oncology Division (22)
  4. Body Imaging Service (14)
  5. GSK Faculty (14)
  6. Molecular Imaging and Therapy Service (13)

More Groups

People
  1. Steven Larson (8)
  2. Michael Morris (6)
  3. Howard Scher (5)
  4. Josef Fox (5)
  5. Gary Schwartz (4)
  6. Leonard Saltz (4)

More People

Years
  1. 2012 (27)
Publications
  1. Journal of Clinical Oncology (25)
  2. American Society of Clinical Oncology Educational Book (2)

Results (27)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • 5-day dosing schedule of temozolomide in relapsed sensitive or refractory small cell lung cancer (SCLC) and methyl-guanine-DNA methyltransferase (MGMT) analysis in a phase II trial
    Meeting Abstract

    Drilon, A. E. D. C.; Kyuichi, K.; Huberman, K. H.; Sima, C. S.; Fiore, J. J.; Yu, H. A.; Varghese, A. M.; Sumner, D. K.; Travis, W. D.; Heguy, A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II trial of the CDK4 inhibitor PD0332991 in CDK4-amplified liposarcoma
    Meeting Abstract

    Dickson, M. A.; Keohan, M. L.; Tap, W. D.; Antonescu, C.; Landa, J.; Qin, L. X.; Dohrenwend, E. G.; Rathbone, D.; Ustoyev, Y.; Condy, M. M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Pharmacodynamic activity of selumetinib to predict radiographic response in advanced uveal melanoma
    Meeting Abstract

    Carvajal, R. D.; Ambrosini, G.; Wolchok, J. D.; Chapman, P. B.; Dickson, M. A.; D'Angelo, S. P.; Bluth, M. J.; Paucar, D.; Fusco, A.; Bohr, D.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • 18F-16 beta-fluoro-5 alpha-dihydrotestosterone (FDHT) PET as a prognostic biomarker for survival in patients with metastatic castrate-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Autio, K. A.; Fox, J. J.; Jia, X.; Heller, G.; Schoder, H.; Humm, J.; Haupt, E. C.; Schneider, C.; Scher, H. I.; Larson, S. M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • (124)I-cG250 PET scan for early detection of response to sunitinib in patients (Pts) with metastatic clear cell renal cell carcinoma (MccRCC)
    Meeting Abstract

    Larson, S. M.; Motzer, R. J.; Pandit-Taskar, N.; Bartz, R.; Feldman, D. R.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase I/II safety and pharmacokinetic (PK) study of ARN-509 in patients with metastatic castration-resistant prostate cancer (mCRPC): Phase I results of a Prostate Cancer Clinical Trials Consortium study
    Meeting Abstract

    Rathkopf, D. E.; Danila, D. C.; Morris, M. J.; Slovin, S. F.; Steinbrecher, J. E.; Arauz, G.; Rix, P. J.; Maneval, E. C.; Chen, I.; Fox, J. J.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Comparison of PSA, FDG-PET, and Prostate Cancer Working Group 2 (PCWG2) criteria to interpret apparent progression on first post-treatment bone scan
    Meeting Abstract

    Autio, K. A.; Fox, J. J.; Haupt, E. C.; Schoder, H.; Scher, H. I.; Larson, S. M.; Morris, M. J.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Malignant progression in intraductal papillary mucinous neoplasms of the pancreas: Results of 157 patients selected for radiographic surveillance
    Meeting Abstract

    LaFemina, J.; Gaujoux, S.; D'Angelica, M. I.; Jarnagin, W. R.; Katabi, N.; Do, K. G.; Brennan, M. F.; Allen, P. J.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase I trial of yttrium 90 resin microspheres in the treatment of colon cancer liver metastases progressing despite hepatic arterial as well as systemic chemotherapy: Preliminary results
    Meeting Abstract

    Sofocleous, C. T.; Kemeny, N. E.; Pandit-Taskar, N.; Do, K. G.; Brody, L. A.; Garcia, A. R.; Capanu, M.; Chou, J. F.; Petre, E. N.; Carrasquillo, J. A.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II study of ganetespib, an hsp-90 inhibitor, in patients with refractory metastatic colorectal cancer
    Meeting Abstract

    Cercek, A.; Shia, J. R.; Gollub, M.; Raasch, P. J.; Hollywood, E.; Reidy, D. L.; Janjigian, Y. Y.; Stadler, Z. K.; Segal, N. H.; O'Reilly, E. M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save